BackEagle Pharmaceuticals Overview

Eagle Pharmaceuticals Research & Development

Research & Development expenses for EGRX.

Quarterly R&D Expenses

$9.83M
↓ 14.02% YoY

As of Jun 30, 2023

Annual R&D Expenses (TTM)

$35.65M
↓ 20.11% YoY

Trailing 12 months ending Jun 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin